Jonathan Terrett
Technik-/Wissenschafts-/F&E-Leiter bei CRISPR THERAPEUTICS AG
Aktive Positionen von Jonathan Terrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CRISPR THERAPEUTICS AG | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Corporate Officer/Principal | 28.02.2017 | - |
Karriereverlauf von Jonathan Terrett
Ehemalige bekannte Positionen von Jonathan Terrett
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | 01.11.2009 | 01.03.2014 |
Technik-/Wissenschafts-/F&E-Leiter | 08.09.2011 | 29.07.2013 | |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech R & D Ltd. is a British company that engages in drug discovery and development. The company is based in Slough, UK. Celltech R&D Ltd. was founded in 1980. | Direktor/Vorstandsmitglied | - | - |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | - | - |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - | - |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Direktor/Vorstandsmitglied | 01.01.2004 | - |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
Corporate Officer/Principal | 06.12.2012 | - |
Ausbildung von Jonathan Terrett
The University of Nottingham | Doctorate Degree |
The University of Sheffield | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Vereinigte Staaten | 3 |
Schweiz | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
Private Unternehmen | 6 |
---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Health Technology |
Celltech R&D Ltd.
Celltech R&D Ltd. Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech R & D Ltd. is a British company that engages in drug discovery and development. The company is based in Slough, UK. Celltech R&D Ltd. was founded in 1980. | Commercial Services |
- Börse
- Insiders
- Jonathan Terrett
- Erfahrung